Insight

Sep 2, 2024, 17:22

Carmine Valenza: The role of gBRCA-PV in post-PARPi myeloid neoplasms, in patients with ovarian cancer

Carmine Valenza, MPH Student at Harvard T.H. Chan School of Public Health, shared a post on X:

“Just out on ESMO Open our last contribution on the role of gBRCA-PV in post-PARPi myeloid neoplasms, in patients with ovarian cancer.

In heavily pretreated patients, gBRCA impact seems to be even higher than PARPi exposure .

Thanks to all the coauthors!

Authors: C.Valenza , M. Mongillo, F.Gigli, D.Trapani, J.Katrini, E.Nicolò, L.Boldrini, L.Boscolo Bielo, G.Castellano, L.Guidi, G.Pellizzari, S.Derio,M.Lapresa, G.Parma, E.Derenzini, G.Curigliano, N.Colombo.

Carmine Valenza: The role of gBRCA-PV in post-PARPi myeloid neoplasms, in patients with ovarian cancer

Source: Carmine Valenza/X

cancer Carmine Valenza D. Trapani E.Derenzini E.Nicolò ESMO Open F.Gigli G Curigliano G.Castellano G.Parma G.Pellizzari gBRCA-PV J.Katrini L. Boscolo Bielo L.Boldrini L.Guidi M. Mongillo M.Lapresa N.Colombo. OncoDaily Oncology Ovarian Cancer post-PARPi myeloid neoplasms S.Derio

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage